Catheter-based septalablation for symptomatic hypertrophic obstructive cardiomyopathy: Follow-up results of the TASH-registry of the German Cardiac Society

Zeitschrift fur Kardiologie

Volumn 94, Issue 8, 2005, Pages 516-523

  Faber, L ^a   Seggewiss, H ^b   Gietzen, F H ^c   Kuhn, H ^d   Boekstegers, P ^e   Neuhaus, L ^f   Seipel, L ^g   Horstkotte, D ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b Leopoldina Krankenhaus   (Germany)

^c Cardiovascular Clinic Bad Neustadt   (Germany)

^d OWL University   (Germany)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^f KLINIKUM KASSEL   (Germany)

^g UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

DDD pacemaker; Hypertrophic obstructive cardiomyopathy; Left ventricular outflow tract gradient; Percutaneous transluminal septal myocardial ablation; Total atrioventricular block; Transcoronary ablation of septal hypertrophy

Indexed keywords

ADULT; AGED; ARTICLE; CATHETER ABLATION; COMPARATIVE STUDY; CONTRAST ECHOCARDIOGRAPHY; CONTROLLED STUDY; DISEASE CLASSIFICATION; DOPPLER FLOWMETRY; FEMALE; FOLLOW UP; GERMANY; HEART HEMODYNAMICS; HEART LEFT ATRIUM; HEART SIZE; HEART VENTRICLE SEPTUM; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROVOCATION; REGISTER; REST; SYMPTOMATOLOGY; THICKNESS; TREATMENT INDICATION; TREATMENT OUTCOME; ADOLESCENT; BLOOD; CLINICAL TRIAL; ECHOCARDIOGRAPHY; HEART OUTFLOW TRACT OBSTRUCTION; HEMODYNAMICS; HYPERTROPHIC CARDIOMYOPATHY; INFORMATION PROCESSING; MATHEMATICAL COMPUTING; MIDDLE AGED; MULTICENTER STUDY; NOTE; PHYSIOLOGY; POSTOPERATIVE COMPLICATION; PROGNOSIS; RECURRENT DISEASE; STATISTICS; SURVIVAL;

CREATINE KINASE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARDIOMYOPATHY, HYPERTROPHIC; CATHETER ABLATION; CREATINE KINASE; DATA COLLECTION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; GERMANY; HEART SEPTUM; HEMODYNAMIC PROCESSES; HUMANS; MALE; MATHEMATICAL COMPUTING; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RECURRENCE; REGISTRIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VENTRICULAR OUTFLOW OBSTRUCTION;

EID: 23744499778     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00392-005-0256-8     Document Type: Article

References (31)

1. (2003) American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. Eur Heart J 24:1965-1991
2. Boekstegers P, Steinbigler P, Molnar A, Schwaiblmair M, Becker A, Knez A, Haberl R, Steinbeck G (2001) Pressure-guided nonsurgical myocardial reduction induced by small septal infarctions in hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 38:846-853
3. Braunwald E (1997) Induced septal infarction: A new strategy for hypertrophic obstructive cardiomyopathy. Circulation 95:1981
4. Chang SM, Lakkis NM, Franklin J, Spencer WHIII, Nagueh SF (2004) Predictors of outcome after alcohol septal ablation therapy in patients with hypertrophic obstructive cardiomyopathy. Circulation 109:824-827
5. Cheitlin, MD, Armstrong, WF, Aurigemma GP et al (2003) ACC/AHA/ ASE 2003 guideline update for the clinical application of echocardiography: Summary article: A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (ACC/ AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). Circulation 108:1146
6. Faber L, Seggewiss H, Gleichmann U (1998) Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Results with respect to intra-procedural myocardial contrast echocardiography. Circulation 98:2415-2421
7. Faber L, Seggewiss H, Fassbender D, Bogunovic N, Strick S, Schmidt HK, Gleichmann U (1998) Perkutane transluminale septale Myokardablation bei HOCM: Akutergebnisse bei 66 Patienten unter Berücksichtigung der Myokard-Kontrastechokardiographie. Z Kardiol 87:191-201
8. Faber L, Meissner A, Ziemssen P, Seggewiss H (2000) Percutaneous transluminal septal myocardial ablation for HOCM: Long-term follow-up in the first series of 25 patients. Heart 83:326-331
9. Faber L, Seggewiss H, Welge D, Fassbender D, Ziemssen P, Schmidt HK, Gleichmann U, Horstkotte D (2003) Vorhersage des Risikos permanenter atrioventrikulärer Überleitungsstörungen nach perkutaner Septumablation bei Patienten mit hypertropher obstruktiver Kardiomyopathie. Z Kardiol 92:39-45
10. Flores-Ramirez R, Lakkis NM, Middleton KJ, Killip D, Spencer WH 3rd, Nagueh SF (2001) Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 37:208-214
11. Gietzen FH, Leuner CJ, Obergassel L, Strunk-Mueller C, Kuhn H (2002) Role of transcoronary ablation of septal hypertrophy in patients with hypertrophic cardiomyopathy, New York Heart Association functional class III or IV, and outflow obstruction only under provocable conditions. Circulation 106:454-459
12. Gietzen FH, Leuner CJ, Raute-Kreinsen U, Dellmann A, Hegselmann J, Strunk-Mueller C, Kuhn H (1999) Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH). Eur Heart J 20:1342-1354
13. Heric B, Lytle BW, Miller OP (1995) Surgical management of hypertrophic obstructive cardiomyopathy. J Thor Cardiovasc Surg 110:195-208
14. Kimmelstiel CD, Maron BJ (2004) Role of percutaneous septal ablation in hypertrophic obstructive cardiomyopathy. Circulation 109:452-456
15. Knight CJ, Kurbaan AS, Seggewiss H, Henein M, Gunning M, Harrington D, Fassbender D, Gleichmann U, Sigwart U (1997) Non-surgical septal reduction for hypertrophic obstructive cardiomyopathy: Outcome in the first series of patients. Circulation 95:2075-2081
16. Kuhn H, Gietzen F, Leuner C, Gerenkamp T (1997) Induction of subaortic septal ischemia to reduce obstruction in hypertrophic obstructive cardiomyopathy. Studies to develop a new catheter-based concept of treatment. Eur Heart J 18:846-851
17. Kuhn H, Seggewiss H, Gietzen FH, Boekstegers P, Neuhaus L, Seipel L (2004) Catheter-based therapy for hypertrophic obstructive cardiomyopathy: First in-hospital outcome analysis of the German TASH Registry Z Kardiol 93:23-31
18. Kuhn H, Gietzen FH, Leuner C, Schaefers M, Schober O, Strunk-Mueller C, Obergassel L, Freick M, Gockel B, Lieder F, Raute-Kreinsen U (2000) Transcoronary ablation of septal hypertrophy (TASH): a new treatment option for hypertrophic obstructive cardiomyopathy. Z Kardiol 89(Suppl 4):IV41-54
19. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH 3rd, Spirito P, Ten Cate FJ, Wigle ED et al (2003) American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 42: 1687-1713
20. Nagueh SF, Ommen SR, Lakkis NM, Killip D, Zoghbi WA, Schaff HV, Danielson GK, Quinones MA, Tajik JA, Spencer WH (2001) Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 38:1707-1710
21. Qin JX, Shiota T, Lever HM, Kapadia SR, Sitges M, Rubin DN, Bauer F, Greenberg NL, Agler DA, Drinko JK, Martin M, Tuzcu EM, Smedira NG, Lytle B, Thomas JD (2001) Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery. J Am Coll Cardiol 38:1994-2000
22. Robbins RC, Stinson EB, Daily PO (1996) Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg 111:586-594
23. Sahn DJ, De Maria AN, Kisslo J, Weyman A (1978) The committee on m-mode standardization of the American Society of Echocardiography. Circulation 58:1072-1078
24. Schulte HD, Gramsch-Zabel H, Schwartzkopff B (1995) Hypertrophische obstruktive Kardiomyopathie: Chirurgische Behandlung. Schweiz Med Wochenschr 125:1940-1949
25. Schulte HD, Bircks W, Lösse B (1987) Techniques and complications of transaortic subvalvular myectomy in patients with hypertrophic obstructive cardiomyopathy (HOCM), Z Kardiol 76(supp3):145-151
26. Seggewiss H, Gleichmann U, Faber L, Fassbender D, Schmidt HK, Strick S (1998) Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Acute results and 3-months follow-up in 25 patients. J Am Coll Cardiol 31:252-258
27. Seggewiss H (2001) Current status of alcohol septal ablation for patients with hypertrophic obstructive cardiomyopathy. Curr Cardiol Rep 3:160-166
28. Sigwart U (1995) Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 346:211-214
29. Spencer WH 3rd, Roberts R (2000) Alcohol septal ablation in hypertrophic obstructive cardiomyopathy: the need for a registry. Circulation 102:600-601
30. Spirito P, Seidman CE, Mc Kenna WJ, Maron BJ (1997) The managemant of hypertrophic cardiomyopathy. New Engl J Med 336:775-785
31. Wigle DE, Rakowski H, Kimball BP, Williams WG (1995) Hypertrophic cardiomyopathy: Clinical spectrum and treatment. Circulation 92:1680-1692